Securing Payer Buy-In to Enhance Patient Access to Your CKD Treatment
Time: 1:30 pm
day: Day 2 Track 3 PM
Details:
- Strategically analyzing optimal avenues for reimbursement generation post-approval
- Emphasizing the significance of educating payers on the burden of CKD and the unmet need of existing therapies
- Establishing robust, evidence-based treatment guidelines, specific to CKD stage or patient subtype, to maximize support from payers and insurers
